If the market is "unmet", how do you know how big the market for Nyrada's product is?!
At $20m MC, NYR have:
- No patent protection
- A large millstone of NOX holding around their necks
- Released no information about their pipeline
- A history of failure in their previous clinical program
- A history of missed and late deadlines
One might argue that at $20m NYR is wildly overvalued...
I am optimistic and hopeful for NYR success but Benoodles, you don't do anyone any favours by constant and ridiculous ramping and false comparisons.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $78.03M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1642 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 682527 | 2 |
View Market Depth
| Last trade - 14.40pm 31/07/2025 (20 minute delay) ? |
| NYR (ASX) Chart |
Day chart unavailable